Find disease awareness content and relevant supporting materials

Flagyl is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause. Flagyl is active against a wide range of pathogenic micro-organisms notably species of Bacteroides , Fusobacteria , Clostridia , Eubacteria , anaerobic cocci and Gardnerella vaginalis . It is also active against Trichomonas , Entamoeba histolytica , Giardia lamblia and Balantidium coli . Flagyl is indicated in adults and children for the following indications: • The prevention of post-operative infections due to anaerobic bacteria, particularly species of Bacteroides and anaerobic streptococci • The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post-operative wound infections from which pathogenic anaerobes have been isolated • Urogenital trichomoniasis in the female ( Trichomonal vaginitis ) and in the male • Bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or Gardnerella vaginitis ) • All forms of amoebiasis (intestinal and extra-intestinal disease and that of symptomless cyst passers) • Giardiasis • Acute ulcerative gingivitis • Anaerobically-infected leg ulcers and pressure sores • Acute dental infections (e.g. acute pericoronitis and acute apical infections) Considerations should be given to official guidance on the appropriate use of antibacterial agents.

Flagyl is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause. Flagyl is active against a wide range of pathogenic micro-organisms notably species of Bacteroides , Fusobacteria , Clostridia , Eubacteria , anaerobic cocci and Gardnerella vaginalis . It is also active against Trichomonas , Entamoeba histolytica , Giardia lamblia and Balantidium coli . Flagyl is indicated in adults and children for the following indications: 1. The prevention of post-operative infections due to anaerobic bacteria, particularly species of Bacteroides and anaerobic streptococci. 2. The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post-operative wound infections from which pathogenic anaerobes have been isolated. 3. Urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male. 4. Bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or Gardnerella vaginitis). 5. All forms of amoebiasis (intestinal and extra-intestinal disease and that of symptomless cyst passers). 6. Giardiasis. 7. Acute ulcerative gingivitis. 8. Anaerobically-infected leg ulcers and pressure sores. 9. Acute dental infections (e.g. acute pericoronitis and acute apical infections). Considerations should be given to official guidance on the appropriate use of antibacterial agents.

1. Treatment of infections in which anaerobic bacteria have been identified or are suspected as pathogens, particularly Bacteroides fragilis and other species of Bacteroides and including other species for which metronidazole is bactericidal, such as Fusobacteria , Eubacteria , Clostridia and anaerobic cocci. Flagyl has been used successfully in: septicaemia, bacteraemia, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, peritonitis and post-operative wound infection from which one or more of these anaerobes have been isolated. 2. Prevention of post-operative infections due to anaerobic bacteria, particularly species of Bacteroides and anaerobic Streptococci.

1. Treatment of infections in which anaerobic bacteria have been identified or are suspected as pathogens, particularly Bacteroides fragilis and other species of Bacteroides and including other species for which metronidazole is bactericidal, such as Fusobacteria , Eubacteria , Clostridia and anaerobic cocci. Flagyl has been used successfully in: septicaemia, bacteraemia, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, peritonitis and post-operative wound infection from which one or more of these anaerobes have been isolated. 2. Prevention of post-operative infections due to anaerobic bacteria, particularly species of Bacteroides and anaerobic Streptococci.

Symbiomix has announced positive results from the second pivotal trial of lead product candidate SYM 1219 (secnidazole) for the treatment...

A Phase III, multi-center, prospective, randomized, double-blind, placebo-controlled study is to evaluate the effectiveness and safety of SYM 1219 from...

Metronidazole is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause. Metronidazole is active against a wide range of pathogenic micro-organisms notably species of Bacteroides , Fusobacteria , Clostridia , Eubacteria , anaerobic cocci and Gardnerella vaginalis . It is also active against Trichomonas , Entamoeba histolytica , Giardia lamblia and Balantidium coli . Metronidazole is indicated in adults and children for the following indications: 1. The prevention of post-operative infections due to anaerobic bacteria, particularly species of Bacteroides and anaerobic streptococci. 2. The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post-operative wound infections from which pathogenic anaerobes have been isolated. 3. Urogenital trichomoniasis in the female ( Trichomonal vaginitis ) and in the male. 4. Bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or Gardnerella vaginitis ). 5. All forms of amoebiasis (intestinal and extra-intestinal disease and that of symptomless cyst passers). 6. Giardiasis. 7. Acute ulcerative gingivitis. 8. Anaerobically-infected leg ulcers and pressure sores. 9. Acute dental infections (e.g. acute pericoronitis and acute apical infections). Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Metronidazole Tablets 200mg is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause. Metronidazole Tablets 200mg is active against a wide range of pathogenic micro- organisms, notably species of Bacteroides, Fusobacteria, Clostridia, Eubacteria, anaerobic cocci and Gardnerella vaginalis. It is also active against Trichomonas vaginalis and other species of trichomonads, Entamoeba histolytica , Giardia lamblia , Balantidium coli and the causative organisms of acute ulcerative gingivitis. Metronidazole Tablets 200mg is indicated in the oral treatment of: The prevention of post-operative infections due to anaerobic bacteria, particularly species of Bacteroides and anaerobic streptococci. The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis and post- operative wound infections from which pathogenic anaerobes have been isolated. Urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male. The male consort of females suffering from urogenital trichomoniasis should be treated concurrently. Bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or Gardnerella vaginitis). All forms of amoebiasis (intestinal and extra-intestinal disease, and that of symptomless cyst passers). Giardiasis. Acute ulcerative gingivitis. Anaerobically-infected leg ulcers and pressure sores. Acute dental infections (e.g. acute pericoronitis and acute apical infections). Considerations should be given to official guidance on the appropriate use of antibacterial agents.